Bausch Health Companies Inc. (TSX: BHC)
BHC trades on the Toronto Stock Exchange in Life Sciences, headquartered in Quebec. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of September 30, 2026. US$ figures convert C$ at 1.4263 C$ per US$, the Bank of Canada daily rate for October 14, 2026. Close and returns: Yahoo Finance daily closes for BHC.TO, last bar 2026-10-14, computed by Sophia Capital. Website: Wikidata.
Profile
| Field | Value |
|---|---|
| Ticker | BHC on the Toronto Stock Exchange |
| Yahoo symbol | BHC.TO |
| Sector | Life Sciences |
| Headquarters | Quebec |
| Listed | 1987-06-29 |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 374,139,613 |
| Also listed on | NYSE |
| Index membership | S&P/TSX Composite |
| SEC CIK | 0000885590 |
| Website | www.bauschhealth.com |
| US listing | BHC |
Returns
| Window | Return |
|---|---|
| 1 day | +0.5% |
| 1 week | -1.9% |
| 1 month | +1.8% |
| 3 months | +25.6% |
| 6 months | +7.0% |
| Year to date | -11.9% |
| 1 year | -1.3% |
| From 52-week high | -23.3% |
| 52-week range | C$6.25 to C$10.95 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
232 documents in 8 types. Each title links to the document at its source.
News release (26)
| Document | Type | Filed |
|---|---|---|
| Press Release of Bausch Health Companies Inc., respecting financial results for the second quarter of 2026 dated July 29, 2026 | News release (8-K) | 2026-07-29 |
| Press release of the Company dated July 1, 2026 | News release (8-K) | 2026-07-01 |
| Press Release of Bausch Health Companies Inc., respecting financial results for the first quarter of 2026 dated April 29, 2026 | News release (8-K) | 2026-04-29 |
| Press Release of Bausch Health Companies Inc., respecting financial results for the fourth quarter and year ended December 31, 2025, dated February… Period 2025-12-31 | News release (8-K) | 2026-02-18 |
Management information circular / proxy (7)
| Document | Type | Filed |
|---|---|---|
| DEF 14A | Proxy statement (DEF 14A) | 2026-04-08 |
| DEFA14A | Proxy statement (DEFA14A) | 2026-04-08 |
| DEF 14A | Proxy statement (DEF 14A) | 2025-08-27 |
| PRE 14A | Proxy statement (PRE 14A) | 2025-08-13 |
Annual report (2)
| Document | Type | Filed |
|---|---|---|
| 10-K Period 2025-12-31 | Annual report (10-K) (10-K) | 2026-02-19 |
| 10-K Period 2024-12-31 | Annual report (10-K) (10-K) | 2025-02-20 |
Quarterly report (6)
| Document | Type | Filed |
|---|---|---|
| 10-Q Period 2026-06-30 | Quarterly report (10-Q) (10-Q) | 2026-07-30 |
| 10-Q Period 2026-03-31 | Quarterly report (10-Q) (10-Q) | 2026-04-30 |
| 10-Q Period 2025-09-30 | Quarterly report (10-Q) (10-Q) | 2025-10-30 |
| 10-Q Period 2025-06-30 | Quarterly report (10-Q) (10-Q) | 2025-07-31 |
Early warning / ownership (9)
| Document | Type | Filed |
|---|---|---|
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2025-08-15 |
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2025-08-14 |
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2025-06-17 |
| Schedule 13D amendment | Schedule 13D (SCHEDULE 13D/A) | 2025-05-21 |
Insider report (92)
| Document | Type | Filed |
|---|---|---|
| Form 3 | Form 3 (3) | 2026-05-20 |
| Form 3 | Form 3 (3) | 2025-08-14 |
| Form 3 | Form 3 (3) | 2025-07-29 |
| Form 3 | Form 3 (3) | 2025-07-29 |
Certification (32)
| Document | Type | Filed |
|---|---|---|
| EX-31.1 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-07-30 |
| EX-31.2 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-07-30 |
| EX-32.1 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-07-30 |
| EX-32.2 Period 2026-06-30 | Certification (SOX 302/906) (10-Q) | 2026-07-30 |
Other (58)
| Document | Type | Filed |
|---|---|---|
| 8-K | Current report (8-K) (8-K) | 2026-07-29 |
| 8-K | Current report (8-K) (8-K) | 2026-07-01 |
| 8-K | Current report (8-K) (8-K) | 2026-05-19 |
| 8-K | Current report (8-K) (8-K) | 2026-04-29 |
Sources: SEC EDGAR filings (public records). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| CURA | Curaleaf Holdings, Inc. | TSX | C$3.4B | -13.3% | -4.0% |
| CRON | Cronos Group Inc. | TSX | C$1.7B | 0.0% | +28.4% |
| APTX | Apotex Health Corp. | TSX | C$7.1B | -16.5% | Under a year of closes |
| WELL | WELL Health Technologies Corp. | TSX | C$1.2B | -3.3% | -20.2% |
| BLCO | Bausch + Lomb Corporation | TSX | C$8.7B | -6.4% | +13.4% |
The app has the price chart, every filing, private raises and the full peer set for BHC.
Open in the app